BRPI0609784C1 - compostos éster de n-alquilcarbonil-aminoácido e n-alquilcarbonil-amino lactona, composição, e, uso de um composto - Google Patents

compostos éster de n-alquilcarbonil-aminoácido e n-alquilcarbonil-amino lactona, composição, e, uso de um composto

Info

Publication number
BRPI0609784C1
BRPI0609784C1 BRPI0609784A BRPI0609784A BRPI0609784C1 BR PI0609784 C1 BRPI0609784 C1 BR PI0609784C1 BR PI0609784 A BRPI0609784 A BR PI0609784A BR PI0609784 A BRPI0609784 A BR PI0609784A BR PI0609784 C1 BRPI0609784 C1 BR PI0609784C1
Authority
BR
Brazil
Prior art keywords
alkylcarbonyl
compound
composition
amino acid
ester compounds
Prior art date
Application number
BRPI0609784A
Other languages
English (en)
Portuguese (pt)
Inventor
Tak Wei Edward
Original Assignee
Alveonix Ag
Axalbion Sa
Tak Wei Edward
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alveonix Ag, Axalbion Sa, Tak Wei Edward filed Critical Alveonix Ag
Publication of BRPI0609784A2 publication Critical patent/BRPI0609784A2/pt
Publication of BRPI0609784A8 publication Critical patent/BRPI0609784A8/pt
Publication of BRPI0609784B1 publication Critical patent/BRPI0609784B1/pt
Publication of BRPI0609784B8 publication Critical patent/BRPI0609784B8/pt
Publication of BRPI0609784C1 publication Critical patent/BRPI0609784C1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/04—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C233/05—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/08—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C233/63—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C07C243/24—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids
    • C07C243/38—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/57—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and carboxyl groups, other than cyano groups, bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/86—Hydrazides; Thio or imino analogues thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D307/85—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Addiction (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
BRPI0609784A 2005-03-29 2006-03-23 compostos éster de n-alquilcarbonil-aminoácido e n-alquilcarbonil-amino lactona, composição, e, uso de um composto BRPI0609784C1 (pt)

Applications Claiming Priority (16)

Application Number Priority Date Filing Date Title
US66716605P 2005-03-29 2005-03-29
US60/667,166 2005-03-29
US60/667166 2005-03-29
US68338405P 2005-05-20 2005-05-20
US60/683,384 2005-05-20
US60/683384 2005-05-20
US70250505P 2005-07-25 2005-07-25
US60/702,505 2005-07-25
US60/702505 2005-07-25
US20372805A 2005-08-13 2005-08-13
US11/203728 2005-08-13
US11/203,728 2005-08-13
US77237406P 2006-02-09 2006-02-09
US60/772,374 2006-02-09
US60/772374 2006-02-09
PCT/GB2006/001093 WO2006103401A2 (en) 2005-03-29 2006-03-23 N-alkylcarbonyl-amino acid ester and n-alkylcarbonyl-amino lactone compounds and their use

Publications (5)

Publication Number Publication Date
BRPI0609784A2 BRPI0609784A2 (pt) 2010-04-27
BRPI0609784A8 BRPI0609784A8 (pt) 2017-07-11
BRPI0609784B1 BRPI0609784B1 (pt) 2020-07-07
BRPI0609784B8 BRPI0609784B8 (pt) 2020-07-21
BRPI0609784C1 true BRPI0609784C1 (pt) 2021-05-25

Family

ID=36498694

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0609784A BRPI0609784C1 (pt) 2005-03-29 2006-03-23 compostos éster de n-alquilcarbonil-aminoácido e n-alquilcarbonil-amino lactona, composição, e, uso de um composto

Country Status (19)

Country Link
US (2) US20110082204A1 (https=)
EP (2) EP2161252A1 (https=)
JP (2) JP2008538115A (https=)
KR (1) KR20070116133A (https=)
CN (1) CN101184725B (https=)
AU (1) AU2006228280B2 (https=)
BR (1) BRPI0609784C1 (https=)
CA (1) CA2602075C (https=)
CY (1) CY1109420T1 (https=)
DE (1) DE602006007831D1 (https=)
DK (1) DK1871738T3 (https=)
ES (1) ES2328847T3 (https=)
IL (1) IL186297A0 (https=)
MX (1) MX2007011831A (https=)
PL (1) PL1871738T3 (https=)
PT (1) PT1871738E (https=)
SI (1) SI1871738T1 (https=)
WO (1) WO2006103401A2 (https=)
ZA (1) ZA200709252B (https=)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102027176B1 (ko) * 2005-03-29 2019-10-01 악살비온 에스아 〔（（1ｒ,2ｓ,5ｒ）―2―이소프로필―5―메틸―시클로헥산카르보닐）―아미노〕―아세트산 이소프로필 에스테르와 관련 화합물 및 요법에서 그의 용도
DE102006047164A1 (de) * 2006-09-29 2008-04-03 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an 2-Isopropyl-5-Methyl-Cyclohexancarbonyl-D-Alaninmethylester und einem oder mehreren Hautbefeuchtungsmitteln
DE102006047162A1 (de) * 2006-09-29 2008-04-03 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit Kombinationen aus (R)-2-[((1R,2S,5R)-2-isopropyl-5-methyl-cyclohexanecarbonyl)-amino]-propionsäure methyl ester und einer oder mehreren Lichtschutzfiltersubstanzen
EP1913976A1 (de) * 2006-10-18 2008-04-23 Symrise GmbH & Co. KG N-alpha-(Menthancarbonyl)aminosäureamide und deren Verwendung als physiologische Kühlwirkstoffe
JP2010509299A (ja) * 2006-11-08 2010-03-25 ウェイ，エドワード，タク Ｎ−アルキルカルボニル−ｄ−アミノ酸ヒドロキシアルキルエステル化合物およびそれらの使用
EP2014333A1 (en) * 2007-07-12 2009-01-14 Hakiman Shargh Research Company Use of cooling agents for treatment or prevention of lacrimation or eye burning
GB2451503B (en) * 2007-08-01 2011-10-12 Lrc Products Stimulating gel comprising a cyclic carboxamide coolant
CN101903023A (zh) * 2007-12-21 2010-12-01 爱德华·塔克·韦 治疗呼吸道疾病的对薄荷烷3-羧酸酯
DE102008015426A1 (de) * 2008-03-20 2009-09-24 Beiersdorf Ag Kühlende kosmetische oder dermatologische Zubereitungen mit einem Gehalt an (1R,2S,5R)-2-Isopropyl-5-methyl-N-(2-(pyridyn-2-yl)ethyl-cyclohexancarboxamid und/oder (1R,2S,5R)-N-(4-(Cyanomethyl)-phenyl)-2-isopropyl-5-methylcyclohexancarboxamid zu Reduktion von Hautrötungen
DE102008015424A1 (de) * 2008-03-20 2009-09-24 Beiersdorf Ag Kühlende kosmetische oder dermatologische Zubereitungen mit einem Gehalt an (1R,2S,5R)-2-Isopropyl-5-methyl-N-(2-(pyridyn-2-yl)ethyl-cyclohexancarboxamid und/oder (1R,2S,5R)-N-(4-(Cyanomethyl)-phenyl)-2-isopropyl-5- methylcyclohexancarboxamid mit Menthoxypropandiol
RU2517179C2 (ru) 2008-08-15 2014-05-27 Дзе Проктер Энд Гэмбл Компани Синтез производных циклогексана, используемых в потребительских товарах в качестве оказывающих сенсорное воздействие веществ
CN102123695A (zh) 2008-08-15 2011-07-13 宝洁公司 用于消费品中的薄荷酰胺溶液
AU2009318056B2 (en) 2008-11-20 2014-07-24 The Procter & Gamble Company Personal care compositions providing enhanced cooling sensation
WO2010139954A1 (en) * 2009-06-05 2010-12-09 Wei Edward Tak Treatment of eye discomfort by topical administration of a cooling agent to the external surface of the eyelid
US9446267B2 (en) 2009-10-06 2016-09-20 Symrise Ag Products comprising a flavoring agent composition
EP2186506B1 (de) 2009-10-06 2015-09-30 Symrise AG Mentholhaltige Zahnputz-Zusammensetzung mit reduzierter Bitterwahrnehmung
JP2013535450A (ja) 2010-07-19 2013-09-12 ザ プロクター アンド ギャンブル カンパニー 精油化合物の誘導体を含む組成物、及びパーソナルケア製品における使用
CN103140209B (zh) 2010-10-01 2017-10-13 宝洁公司 具有改善的风味的口腔护理组合物
CA2819466C (en) * 2010-12-06 2019-11-26 Axalbion Sa [((1r,2s,5r)-2-isopropyl-5-methyl-cyclohexanecarbonyl)-amino]-acetic acid isopropyl ester and related compounds and their use in therapy
CA2824827A1 (en) 2011-01-18 2012-07-26 Edward Tak Wei (r)-1,2-propanediol for use as a solvent in therapeutic cooling agent compositions
US8426463B2 (en) * 2011-04-04 2013-04-23 Edward T. Wei [((1R,2S,5R)-2-isopropyl-5-methyl-cyclohexanecarbonyl)-amino]-acetic acid isopropyl ester and related compounds and their use in therapy
US20130042482A1 (en) 2011-08-16 2013-02-21 Valerie Jean Bradford Skin Engaging Member Comprising An Anti-Irritation Agent
CN103930091B (zh) 2011-09-01 2016-03-02 宝洁公司 具有改善的流变特性的口腔护理组合物
US20150272161A1 (en) * 2011-12-21 2015-10-01 Wm. Wrigley Jr. Company Chewing gum products containing (r)-2-[((1r,2s,5r)-2-isopropyl-5-methylclohexanecarbonyl)-amino]-acetic acid isopropyl ester
US20130315843A1 (en) 2012-05-25 2013-11-28 The Procter & Gamble Company Composition for reduction of trpa1 and trpv1 sensations
MX354139B (es) 2012-09-28 2018-01-08 Gillette Co Llc Un miembro auxiliar de afeitado de acoplamiento con la piel que comprende al menos un agente percibido por los sentidos termicamente resilente.
AU2013323690B2 (en) 2012-09-28 2016-09-22 The Gillette Company Llc A skin engaging member comprising at least one thermally resilient sensate
US9265458B2 (en) 2012-12-04 2016-02-23 Sync-Think, Inc. Application of smooth pursuit cognitive testing paradigms to clinical drug development
US9380976B2 (en) 2013-03-11 2016-07-05 Sync-Think, Inc. Optical neuroinformatics
AU2013403622B2 (en) 2013-10-22 2019-05-16 Edward Tak Wei Di-isopropyl-phosphinoyl-alkane (DAPA) compounds as topical agents for the treatment of sensory discomfort
AU2013403623A1 (en) 2013-10-22 2016-06-09 Edward Tak Wei 1-di(sec-butyl)-phosphinoyl-pentane (DAPA-2-5) as a topical agent for the treatment of discomfort from non-keratinized stratified epithelial (NKSE) tissue
US9884130B2 (en) 2013-11-13 2018-02-06 The Procter & Gamble Company Compositions for delivery of oral comfort sensations
CN106029175A (zh) 2014-02-27 2016-10-12 宝洁公司 具有减少的苦味感受的口腔护理组合物
US20150272847A1 (en) 2014-03-26 2015-10-01 The Gillette Company Skin Engaging Shaving Aid Comprising A Thermally Resilient Sensate And A TRPA1 Receptor Inhibitor
US20150273711A1 (en) 2014-03-26 2015-10-01 The Gillette Company Razor Comprising A Molded Shaving Aid Composition Comprising A Thermally Resilient Sensate
JP2017518963A (ja) 2014-04-23 2017-07-13 ザ プロクター アンド ギャンブル カンパニー 生体表面付着組成物
MX2017002100A (es) 2014-08-15 2017-05-04 Procter & Gamble Dentifrico con sustancias quimicas incrementales.
CA2956964C (en) 2014-08-15 2019-07-16 The Procter & Gamble Company Oral care compositions with an enhanced sensory experience
EP3180090A1 (en) 2014-08-15 2017-06-21 The Procter and Gamble Company Oral care compositions and regimens
BR112017011022B1 (pt) 2014-11-26 2021-02-17 The Gillette Company Llc dispositivo de remoção de pelo e processo de formação de um membro de engate à pele
US9951295B2 (en) 2015-02-19 2018-04-24 The Procter & Gamble Company Compositions for deposition on biological surfaces
AR104220A1 (es) 2015-04-09 2017-07-05 Procter & Gamble Reducción de la aversión al sabor del cpc mediante la reducción de la activación del cpc de los receptores de trpa1, receptores de trpv1, o ambos
MX2017017169A (es) * 2015-06-30 2018-03-09 Wrigley W M Jun Co Formulaciones refrigerantes de larga duracion.
EP3365324A1 (en) 2015-10-22 2018-08-29 The Procter and Gamble Company Synthesis of cyclohexane carboxamide derivatives useful as sensates in consumer products
JP2018533567A (ja) 2015-10-22 2018-11-15 ザ プロクター アンド ギャンブル カンパニー クロマトグラフィー分離方法
CN108368035A (zh) 2015-12-18 2018-08-03 宝洁公司 在消费品中可用作感觉剂的环己烷酯衍生物的合成
CA3018559A1 (en) 2016-04-01 2017-10-05 The Procter & Gamble Company Oral care compositions with an effective flavor display
EP3435957A1 (en) 2016-04-01 2019-02-06 The Procter and Gamble Company Oral care compositions containing gel networks and potassium nitrate
BR112018069874A2 (pt) 2016-04-01 2019-02-05 Procter & Gamble composições para tratamento bucal contendo uma fase de rede de gel e nitrato de potássio
AU2017240034B2 (en) 2016-04-01 2020-02-06 The Procter & Gamble Company Oral care compositions containing a gel network phase
AU2017240683B2 (en) 2016-04-01 2020-01-16 The Procter & Gamble Company Oral care compositions containing potassium nitrate and peroxide
US20170334082A1 (en) 2016-05-18 2017-11-23 The Gillette Company Llc Skin Engaging Member Comprising Ethylene Vinyl Acetate
WO2018081190A1 (en) 2016-10-25 2018-05-03 The Procter & Gamble Company Fibrous structures
WO2018081189A1 (en) 2016-10-25 2018-05-03 The Procter & Gamble Company Fibrous structures
WO2018085479A1 (en) 2016-11-03 2018-05-11 The Gillette Company Llc Skin engaging member comprising ethylene vinyl acetate
EP3541476A1 (en) 2016-11-17 2019-09-25 The Gillette Company LLC Skin engaging member comprising ethylene vinyl acetate and a fragrance
WO2018144678A1 (en) * 2017-02-03 2018-08-09 The Johns Hopkins University Mini-cancers utilization for personalized cancer drug regimens
EP3801449A1 (en) 2018-05-28 2021-04-14 The Procter & Gamble Company Oral care composition with improved deposition efficacy of a cooling sensate agent in the oral cavity
KR102132713B1 (ko) 2018-12-04 2020-07-13 주식회사 오스테온 모발 또는 두피 상태 개선용 조성물
GB201908219D0 (en) * 2019-06-10 2019-07-24 Axalbion Sa Therapeutic use of a compound
MX2023003549A (es) 2020-09-28 2023-04-21 Procter & Gamble Composiciones para el cuidado bucal que comprenden lupulo y saborizante.
JP7592526B2 (ja) * 2021-03-19 2024-12-02 株式会社マンダム Ｔｒｐｖ１活性抑制剤、およびその利用
US12397518B2 (en) * 2021-04-29 2025-08-26 Coopervision International Limited WS12-releasing contact lens
EP4337157A1 (en) 2021-05-11 2024-03-20 The Procter & Gamble Company Oral care compositions comprising block copolymer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4136163A (en) * 1971-02-04 1979-01-23 Wilkinson Sword Limited P-menthane carboxamides having a physiological cooling effect
PH10359A (en) * 1971-02-04 1977-01-05 Wilkinson Sword Ltd N-substituted-p-methane-3-carboxamides having physiological cooling activity and compositions containing them
US4178459A (en) * 1971-02-04 1979-12-11 Wilkinson Sword Limited N-Substituted paramenthane carboxamides
US4150052A (en) * 1971-02-04 1979-04-17 Wilkinson Sword Limited N-substituted paramenthane carboxamides
GB1351761A (en) * 1971-02-04 1974-05-01 Wilkinson Sword Ltd Substituted p-menthane carboxamides and compositions containing them
US3889804A (en) * 1973-03-14 1975-06-17 Gorham Int Inc Disposable towel
JP2978043B2 (ja) * 1993-09-16 1999-11-15 高砂香料工業株式会社 （２ｓ）−３−｛（１ｒ，２ｓ，５ｒ）−［ ５−メチル−２−（１−メチルエチル）シクロヘキシル ］オキシ｝−１，２−プロパンジオール，その製造方法および用途
US7189760B2 (en) * 2004-04-02 2007-03-13 Millennium Specialty Chemicals Physiological cooling compositions containing highly purified ethyl ester of N-[[5-methyl-2-(1-methylethyl) cyclohexyl] carbonyl]glycine
US20080227857A1 (en) * 2005-03-29 2008-09-18 Edward Tak Wei N-Alkylcarbonyl-Amino Acid Ester and N-Alkylcarbonyl-Amino Lactone Compounds and Their Use

Also Published As

Publication number Publication date
AU2006228280B2 (en) 2012-08-30
ZA200709252B (en) 2009-04-29
BRPI0609784A2 (pt) 2010-04-27
CA2602075A1 (en) 2006-10-05
CN101184725B (zh) 2012-03-21
HK1106761A1 (en) 2008-03-20
DK1871738T3 (da) 2009-09-21
MX2007011831A (es) 2007-11-21
BRPI0609784A8 (pt) 2017-07-11
DE602006007831D1 (de) 2009-08-27
BRPI0609784B8 (pt) 2020-07-21
EP1871738A2 (en) 2008-01-02
EP2161252A1 (en) 2010-03-10
JP2008538115A (ja) 2008-10-09
WO2006103401A3 (en) 2007-03-08
US20110152366A1 (en) 2011-06-23
PL1871738T3 (pl) 2009-12-31
SI1871738T1 (sl) 2009-12-31
CY1109420T1 (el) 2014-08-13
US8853267B2 (en) 2014-10-07
BRPI0609784B1 (pt) 2020-07-07
US20110082204A1 (en) 2011-04-07
AU2006228280A1 (en) 2006-10-05
JP2011068656A (ja) 2011-04-07
KR20070116133A (ko) 2007-12-06
PT1871738E (pt) 2009-09-11
ES2328847T3 (es) 2009-11-18
IL186297A0 (en) 2008-01-20
CA2602075C (en) 2014-04-29
EP1871738B1 (en) 2009-07-15
WO2006103401A2 (en) 2006-10-05
CN101184725A (zh) 2008-05-21

Similar Documents

Publication Publication Date Title
BRPI0609784C1 (pt) compostos éster de n-alquilcarbonil-aminoácido e n-alquilcarbonil-amino lactona, composição, e, uso de um composto
BR112022024120A2 (pt) Derivado de piridina-pirimidina, método de preparação do mesmo e uso farmacêutico do mesmo
CR9949A (es) Inhibidores de proteina activadora de la 5-lipoxigenasa (flap)
BR112012009376A2 (pt) composição farmacêutica, forma de dosagem farmacêutica, processo para a sua preparação, métodos de tratamento e seu uso
BRPI0809164B8 (pt) Composição para administração tópica e composição farmacêutica compreendendo a referida composição
BR112012010058A2 (pt) aplicador tópico para um agente paralítico e método para aplicação do agente
IN2012DN01435A (https=)
BR112014007654A8 (pt) Inibidores de lrrk2 quinase macrocíclicos.
BR112013027034A8 (pt) "compostos para o tratamento de transtornos neuropsiquiátricos."
BR112013003847A8 (pt) métodos de tratar a deterioração cognitiva moderada (mci) e os distúrbios relacionados
EP2305640A3 (en) Substituted diphenyl-ethers, -amines, -sulfides and -methanes for the treatment of respiratory diseases
WO2007093880A3 (en) Novel pyrone-indole derivatives and process for their preparation
BR112015011213A2 (pt) Composto, composição farmacêutica, método de prevenção ou tratamento de um distúrbio ou doença de controle respiratório em um indivíduo, método de prevenção de desestabilização ou de estabilização do ritmo respiratório em um indivíduo, método de preparação de o,n-dimetil-n-[4-(n-propilamina)-6-(prop-2-inilamina)-[1,3,5]triazin-2-il]-hidroxilamina, e composição.
DOP2007000053A (es) Compuestos de tetrahidropiridotienopirimidina y métodos para su empleo
NO20063047L (no) Vandige ciclesonidsuspensjoner for forstoving
WO2012134194A3 (en) Herbal compositions for treating neurological diseases and improving memory impairment
BR112012003464B8 (pt) compostos de piranil aril metil benzoquinaozlinona, uso dos mesmos, e, composição farmacêutica
BR112015000321A2 (pt) formulações de laquinimod sem agente alcalinizante
ATE555116T1 (de) Ahcy-hydrolasehemmer zur behandlung von hyperhomocysteinämie
WO2007046097A3 (en) Topical compositions for the treatment of depilation-induced skin irritation or prevention thereof
BRPI0607536A2 (pt) tratamento de dor
BRPI0801239A2 (pt) uso de um ou mais benzopiranonas, composição farmacêutica e método de prevenção ou tratamento de doenças, disfunções e distúrbios associados a monoamino oxidase
BRPI0508177A (pt) composto, processo para a produção do composto, composição farmacêutica, uso do composto método para o tratamento de uma doença e produto de combinação
BRPI0414786A (pt) extrato de mahonia aquifolium, processo de extração e composição farmacêutica contendo o mesmo
BRPI0808353B8 (pt) usos de amidas do ácido 3-aril-3-hidróxi-2-amino-propiônico, amidas do ácido 3-heteroaril-3-hidróxi-2-amino-propiônico e compostos relacionados

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: ALVEONIX AG (CH)

B25A Requested transfer of rights approved

Owner name: AXALBION SA (CH)

B25L Entry of change of name and/or headquarter and transfer of application, patent and certificate of addition of invention: publication cancelled

Owner name: AXALBION SA (CH)

B25A Requested transfer of rights approved

Owner name: AXALBION SA (CH)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 07/07/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: REF. RPI 2583 DE 07/07/2020 QUANTO AO TITULO.

B16D Grant of patent or certificate of addition of invention cancelled

Free format text: ANULADA A PUBLICACAO CODIGO 16.1 DA RPI NO 2583 DE 07/07/2020 E A PUBLICACAO DE CODIGO 16.3 DA RPI 2585 DE 21/07/2020 POR TEREM SIDO INDEVIDAS.

B09X Republication of the decision to grant [chapter 9.1.3 patent gazette]

Free format text: REFERENCIA: RPI 2578 DE 02/06/2020 (9.1)

B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 06/04/2021, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 23/03/2006 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF